Browsing by Author Hacker, Neville F.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 20
Issue DateTitleAuthor(s)Citation
2015Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancerColvin, Emily; Howell, Viive; Yuen, Samuel; Brown, Laura; Chang, David K.; et al, Various; Gloss, B; Hacker, Neville F.; Jones, Marc; Moran-Jones, Kim; Murali, Rajmohan; Scarlett, C J; Spong, Suzanne; Wong, Carol; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling InstituteConnective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer, Oncotarget, vol.6, 42, 2015,pp 44551-44562
2006A distinct molecular profile associated with mucinous epithelial ovarian cancer.Baron-Hay, Sally; Scolyer, Richard; Scott, Carolyn; Bali, A.; et, al; Fink, Daniel; Gardiner-Garden, Margaret; Hacker, Neville F.; Heinzelmann-Schwarz, Viola A.; Henshall, Susan M.; Scurry, Jame P.; Smith, Alison N.; Vanden Bergh, P.; Clinical Schools; Central Clinical School: Pathology; Northern Clinical School: Molecular Medicine (Kolling I)A distinct molecular profile associated with mucinous epithelial ovarian cancer., British Journal of Cancer, vol.94,(6),2006,pp 904-913
2017Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian CancerdeFazio, Anna; Emmanuel, Catherine; Kennedy, Catherine Jane; Ford, C; Hacker, Neville F.; Henry, C; Kan, B; Lambie, N; Loo, C; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Obstetrics & GynaecologyDistinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer, Translational Oncology, vol.10, 3, 2017,pp 346-356
2003EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancerCampbell, Ian; Davies, Michael; Mann, Graham; Anderson, David W; Bova, Ronaldo J; Brady, Ged; Choong, David YH; Clancy, Jennifer L; Hacker, Neville F.; Henderson, Michelle J; Henshall, Susan M.; Macdonald, Graeme A; Nolan, Tania; Olopade, Olufunmilayo I; Russell, Amanda J; Segara, Davendra; Sutherland, Robert L.; Watts, Colin KW; Woollatt, Erica; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Heart Research Institute; Western Clinical School: Westmead Millennium InstituteEDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer, Oncogene, vol.22,(32),2003,pp 5070-5081
2014Effects of access to and treatment in specialist facilities on survival from epithelial ovarian cancer in Australian women: a data linkage studyArmstrong, Bruce; Tracey, Elizabeth; Young, Jane; Hacker, Neville F.; School of Public Health: Public Health; School of Public Health: Public Health; School of Public Health: Public HealthEffects of access to and treatment in specialist facilities on survival from epithelial ovarian cancer in Australian women: a data linkage study, International Journal Of Gynecological Cancer, vol.24, 7, 2014,pp 1232-1240
2003Incidence of microsatellite instability in synchronous tumors of the ovary and endometriumBarnetson, Rebecca; Harnett, Paul; Kirk, Judy; Shannon, C; Crandon, Alex; Evans, Justin; Hacker, Neville F.; Quinn, Michael; Schnitzler, Margaret; Northern Clinical School: Kolling Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; MedicineIncidence of microsatellite instability in synchronous tumors of the ovary and endometrium, Clinical Cancer Research, vol.9,(4),2003,pp 1387-1392
2006Low meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries.Baron-Hay, Sally; Scolyer, Richard; Scott, Carolyn; Biankin, Andrew V.; Fink, Daniel; Gardiner-Garden, Margaret; Hacker, Neville F.; Heinzelmann-Schwarz, Viola A.; O'Brien, Philippa M.; Scurry, Jame P.; Smith, Alison N.; Sutherland, Robert L.; Ward, Robyn N.; Clinical Schools; Central Clinical School: Pathology; Northern Clinical School: Molecular Medicine (Kolling I)Low meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries., Journal of Clinical Pathology 2005, vol.60,(6),2006,pp 622-626
2010MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcomeByrne, Jennifer; deFazio, Anna; Emmanuel, Catherine; Fanayan, Susan; Murali, Rajmohan; Gloss, B; Hacker, Neville F.; Hardy, Jayne; Maleki, Sanaz; O'Brien, Philippa M.; Scurry, James P.; Sutherland, Robert L.; Children's Hospital Westmead: Paediatrics & Child Health; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Northern Clinical School: Kolling Institute; Central Clinical School: PathologyMAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome, BMC Cancer, vol.10, 497,pp 1-11
2014Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasmaArmstrong, Nicola Joy; Clark, Susan; Gloss, B; Hacker, Neville F.; Kaplan, Warren; Lin, Vita ap; Mangs, Helena; Nair, S; Navin, Tina; Samimi, Goli; Sutherland, R; Warton, Kristina; Ying, Kevin; Mathematics & StatisticsMethylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma, BMC Genomics, vol.15, 476, 2014,pp 1-13
2015Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada: Results from two large cancer facilitiesKang, Yoon-Jung; O'Connell, Dianne; Barton, Michael; Canfell, Karen; Delaney, Geoff; Demers, Alain A.; Hacker, Neville F.; Jackson, Michael; Kliewer, Erich; Lew, Jie-Bin; Lotocki, Robert; Tan, Jeffrey; School of Public Health: Public Health; School of Public Health: MedicineOptimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada: Results from two large cancer facilities, Cancer Epidemiology, vol.39, 4, 2015,pp 600-611
2009Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancerGebski, Val; Hacker, Neville F.; Marsden, Donald E; Robertson, Greg; Tantipalakorn, Charuwan; School of Public Health: NH&MRC Clinical Trials CentreOutcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer, Obstetrics and Gynecology, vol.113, 4, 2009,pp 895-901
2003Post-treatment sexual adjustment following cervical and endometrial cancer: a qualitative insightButow, Phyllis; Juraskova, Ilona; Sharpe, Louise; Hacker, Neville F.; McLeod, C; Robertson, R; Psychology; Psychology; PsychologyPost-treatment sexual adjustment following cervical and endometrial cancer: a qualitative insight, Psycho-Oncology, vol.12,(3),2003,pp 267-279
2005Presenting symptoms of epithelial ovarian cancer.Gebski, Val; Hacker, Neville F.; Lataifeh, Isam; Marsden, Donald E; Robertson, Greg; School of Public Health: NH&MRC Clinical Trials CentrePresenting symptoms of epithelial ovarian cancer., Australian and New Zealand Journal of Obstetrics and Gynaecology 2005, vol.45,(3),2005,pp 211-4
2013Primary surgical management with tailored adjuvant radiation for stage IB2 cervical cancerFriedlander, Michael; Gebski, Val; Barlow, Ellen; Farrell, Rhonda; Hacker, Neville F.; Jackson, Michael; Robertson, Greg; Scurry, James P; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentrePrimary surgical management with tailored adjuvant radiation for stage IB2 cervical cancer, Obstetrics and Gynecology, vol.121, 4, 2013,pp 765-772
2014Quality of life after complete lymphadenectomy for vulvar cancer: do women prefer sentinel lymph node biopsy?Gebski, Val; Farrell, Rhonda; Hacker, Neville F.; School of Public Health: NH&MRC Clinical Trials CentreQuality of life after complete lymphadenectomy for vulvar cancer: do women prefer sentinel lymph node biopsy?, International Journal of Gynecological Cancer, vol.24, 4, 2014,pp 813-819
2002Secondary Cytoreduction Surgery for Recurrent Epithelial Ovarian CancerGebski, Val; Grant, P; Hacker, Neville F.; Tay, E; School of Public Health: NH&MRC Clinical Trials CentreSecondary Cytoreduction Surgery for Recurrent Epithelial Ovarian Cancer, Obstetrics and gynecology, vol.100,(6),2002,pp 1359-1360
2002Secondary cytoreductive surgery for recurrent epithelial ovarian cancerGebski, Val; Grant, Peter T; Hacker, Neville F.; Tay, Eng-Hseon; School of Public Health: NH&MRC Clinical Trials CentreSecondary cytoreductive surgery for recurrent epithelial ovarian cancer, Obstetrics and gynecology, vol.99,(6),2002,pp 1008-1013
2007Thromboembolic complications in patients with clear cell carcinoma of the ovaryGebski, Val; Hacker, Neville F.; Marsden, Donald E; Matsuura, Yusuke; Robertson, Greg; Soo-Nyung, Kim; School of Public Health: NH&MRC Clinical Trials CentreThromboembolic complications in patients with clear cell carcinoma of the ovary, Gynecologic oncology, vol.104,(2),2007,pp 406-410
2006Thromboembolic complications in patients with clear cell carcinoma of the ovary.Gebski, Val; Hacker, Neville F.; Kim, Soo-Nyung; Marsden, Donald E; Matsuura, Yusuke; Robertson, Greg; School of Public Health: NH&MRC Clinical Trials CentreThromboembolic complications in patients with clear cell carcinoma of the ovary., Gynecologic oncology, vol.104,(2),2006,pp 406-410
2017Vulvar cancer in high-income countries: Increasing burden of diseaseCanfell, Karen; Barlow, Ellen; Coffey, Kate; Hacker, Neville F.; Kang, Yoon-Jung; Smith, Megan A; School of Public Health: Public HealthVulvar cancer in high-income countries: Increasing burden of disease, International Journal of Cancer, vol.141, 11, 2017,pp 2174-2186